...

首页> 外文期刊>International Journal of Hematology and Oncology >Seroprevalence of HTLV I-II, HIV and HCV Antibodies in Lymphoma, Head and Neck Cancer Patients

【24h】

Seroprevalence of HTLV I-II, HIV and HCV Antibodies in Lymphoma, Head and Neck Cancer Patients

机译：HTLV I-II，HIV和HCV抗体在淋巴瘤，头颈癌患者中的血清阳性率

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Hematology and Oncology》 |2016年第4期|共页
作者
Mustafa BENEKLI; Nuray BUYUKBERBER; Ramazan YILDIZ; Tulay YALCINKAYA; Ugur COSKUN;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Seroprevalence of HCV and HIV Antibodies in Tuberculosis Confirmed Patients in Ekiti State, Nigeria [J] . O. Ojo-Bola, T. Fagbuyiro, T. O. Korode, International Journal of TROPICAL DISEASE & Health . 2019,第1期

机译：尼日利亚埃基蒂州结核病确诊患者中HCV和HIV抗体的血清阳性率
2. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study. [J] . Schrijvers D, Van Herpen C, Kerger J, Annals of oncology: official journal of the European Society for Medical Oncology . 2004,第4期

机译：多西他赛，顺铂和5-氟尿嘧啶治疗局部晚期不可切除的头颈癌患者：I-II期可行性研究。
3. A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. [J] . Wong RK, Jones GW, Sagar SM, International Journal of Radiation Oncology, Biology, Physics . 2003,第2期

机译：一项I-II期研究，涉及使用针刺样经皮神经刺激治疗接受放射线治疗的头颈部癌症患者的放射诱发的口干症。
4. HCV-related Factors but not HIV-Related Factors at Baseline Predict the Response to Treatment With Peginterferon alfa-2a (40KD) (PEGASYS) Plus Ribavirin (COPEGUS) in Patients With HCV/HIV Co-infection: Predictor Analysis From the APRICOT Study [C] . D. Cooper, F.J. Torriani, M. Rodriguez Torres International AIDS Conference . 2004

机译：HCV相关因素但基线上没有艾滋病毒相关因素预测与HCV / HIV共感染患者的Peginterferon Alfa-2a（40kd）（Pegasys）（Pegasys）加利巴韦林（Copegus）对治疗的反应：来自杏研究的预测因素分析
5. National and Institutional Outcomes Data in Head and Neck Cancers, and Functional and Patient Reported Outcomes in Patients with Oropharyngeal Cancers. [D] . Kansal, Ankit. 2017

机译：头颈癌的国家和机构结局数据，以及口咽癌患者的功能和患者报告结局。
6. Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab short-course radiotherapy and cyclophosphamide [O] . Marco C. Merlano, Anna M. Merlotti, Lisa Licitra, 2018

机译：复发转移性头颈癌患者的免疫应答激活（CONFRONT I-II期试验）：联合使用avelumab的多模式免疫疗法短程放疗和环磷酰胺
7. Initial evaluation of (4S)-4-(3-18Ffluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma [O] . Sonya Y. Park, Camila Mosci, Meena Kumar, 2020

机译：初始评价（4S）-4-（3- 18F氟丙基）-1-谷氨酸（FSPG）PET / CT成像，头颈癌，结直肠癌或非霍奇金淋巴瘤患者

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号